This is a working overview of heptapeptide, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-02-04 and is reviewed periodically as new material appears.
Lyophilised material is stable for extended periods when kept dry and cold, and suppliers typically recommend storage well below freezing. Once dissolved, the peptide is handled at refrigeration temperatures and used within a short period, because peptide bonds and the acetylated terminus can be affected by repeated freeze-thaw cycles, proteases, or extreme pH. Bacteriostatic water and saline are both described as solvents, although preservatives can interfere with some analytical workflows. Reconstituted solutions are inspected for particulates before use.
Sports authorities classify the peptide as a prohibited substance, and it appears on the World Anti-Doping Agency list under peptide hormones, growth factors, and related substances. Racing jurisdictions for horses and dogs have issued separate restrictions, and several national bodies treat it as a controlled or prescription-only item. As a research chemical it is sold without a therapeutic indication, and labels usually state that the product is not for human or veterinary use. Regulatory treatment therefore varies by country.
TB-500 is a synthetic seven-amino-acid peptide with the sequence LKKTETQ, corresponding to residues 17 through 23 of the protein thymosin beta-4. The N-terminus is typically acetylated in the described form, giving a monoisotopic mass near 888.5 Da and an average mass of about 889 Da. The designation TB-500 is a catalogue label rather than a formal chemical name, and the same sequence appears in the literature under several alternative abbreviations. It is handled as a research reagent rather than a pharmaceutical product.
Thymosin beta-4 is a 43-residue actin-binding protein found in most mammalian cell types, where it participates in cytoskeletal regulation and cell migration. TB-500 represents only a short fragment of that protein and does not include the remaining residues. Whether the isolated fragment reproduces the full range of activities reported for the intact protein remains an open question. Researchers commonly treat the two as related but distinct entities when comparing results.
| Property | Value | Notes |
|---|---|---|
| Analytical method | LC-MS/MS | Preferred confirmatory technique |
| Appearance | White to off-white powder | Lyophilised form |
| Solubility | Freely soluble in water | Also described in saline |
| Storage temperature | Below -20 °C for powder | Short-term refrigeration for solutions |
| Regulatory status | Prohibited in sport | Listed under peptide hormones |
TB-500 is a research peptide whose sequence matches residues 17 to 23 of thymosin beta-4, a 43-residue protein present in most mammalian cells. The chain is seven amino acids long, written as LKKTETQ, and is normally supplied with an acetyl group on the N-terminus. Suppliers list it as a lyophilised powder under the code name TB-500, and the same sequence appears elsewhere in catalogues as the thymosin beta-4 actin-binding fragment. The label is commercial rather than systematic, so no single authority fixes exactly what TB-500 denotes.
Thymosin beta-4 was isolated from calf thymus in the early 1980s and later characterised as an abundant intracellular actin-sequestering protein. Interest in short synthetic fragments grew once the actin-binding motif had been mapped to the middle of the sequence. TB-500 came out of that line of work as a truncated analogue rather than a natural isolate, and it is now sold mainly to laboratories. Published studies on the fragment have been largely in vitro or in animal models, and controlled human trials remain sparse, so claims about effects in people rest on extrapolation.
Literature and online discussion often conflate TB-500 with full-length thymosin beta-4, even though the two differ in size and are not interchangeable in analytical terms. The fragment is produced by solid-phase peptide synthesis, and the product is a defined seven-residue chain rather than a biological extract. Because the term is a trade-style label, two vendors may supply materials of the same nominal sequence but different counter-ion content, purity, or water content. Comparisons across studies are therefore difficult unless the exact sequence and purity are reported.
Lyophilised peptide is normally reconstituted with sterile water or a neutral buffer shortly before use. Because repeated freeze-thaw cycles can degrade the material, dividing a reconstituted solution into single-use aliquots is a common practice. Working solutions are usually kept cold and protected from light. The exact shelf life depends on concentration, buffer composition, and handling, so it is often determined empirically rather than assumed.
Peptide bonds are susceptible to hydrolysis under extreme pH and to enzymatic cleavage if proteases are present. Heat, oxidising agents, and prolonged exposure to light also contribute to loss of material. Aggregation can occur at high concentrations or in certain buffer systems, and it may not be visible to the eye. Storage at -20 C or below is typical for both powder and aliquoted solutions, and desiccation of the powder is preferred.
Lyophilised peptide powders are hygroscopic, and the fragment absorbs atmospheric moisture when a vial is opened at room temperature. Weighing and aliquoting are normally done quickly in a dry environment, and stock solutions are divided into single-use portions before freezing. Repeated freeze-thaw cycles are avoided because they promote aggregation and can shift the measured content of a vial. These practices are general to synthetic peptides rather than unique to this sequence, but they matter more for short chains kept for long periods.
The seven-residue chain carries several polar and charged side chains, so it dissolves readily in water and in aqueous buffers near neutral pH. No cysteine is present, so disulphide formation is not a concern and reducing agents are unnecessary. Dilute ammonium hydroxide or acetonitrile-water mixtures are sometimes used for stock solutions when initial dissolution is slow. Strongly alkaline conditions and prolonged contact with oxidising agents are avoided because they can modify lysine-containing stretches, and haze in solution usually signals incomplete dissolution or aggregated material.
Half-Life 2 is a 2004 first-person shooter (FPS) game developed and published by Valve Corporation. It was published for Windows on Valve's digital distribution service, Steam. Like the original Half-Life (1998), Half-Life 2 combines combat, puzzles and storytelling, and adds features such as vehicles and physics-based gameplay. The player controls Gordon Freeman, who joins a resistance effort to liberate Earth from the alien Combine empire. Half-Life 2 was created using Valve's Source game engine, which was developed simultaneously. Development lasted five years and cost US $40 million. Valve's president, Gabe Newell, set his team the goal of redefining the FPS genre. They integrated the Havok physics engine, which simulates real-world physics, to reinforce the sense of presence and create new gameplay. They also developed the characterization, with more detailed character models and animations. Valve announced Half-Life 2 at E3 2003 with a release date of September of that year. They failed to meet the release date, leading to fan backlash. In October, the unfinished source code was published online, leading to more backlash and damage to the team's morale. Half-Life 2 was released on Steam on November 16, 2004. It won 39 Game of the Year awards and, like its predecessor, has been cited as one of the most influential FPS games and among the greatest games ever made. It was ported to the Xbox, the Xbox 360, the PlayStation 3, macOS, and Linux. By 2011, it had sold 12 million copies.
Open fuel cycle: the cycle starts with the mining of uranium, goes through the fuel fabrication and ends with the direct disposal of the spent fuel. Closed fuel cycle: the spent fuel stored for a long time can be safely handled and it undergoes reprocessing in order to recover and recycle a large amount of it.
On August 8, 2019, the Ford government severed the funding for court-ordered autism services for eight families with adult children with "severe" conditions who are at "serious risk of harm", who had been receiving the funding since 2004. Lawyers Scott Hutchison and Mary Eberts served notice of intent to sue in an 18-page letter to Social Services Minister Smith and Premier Ford "for breach of contract, negligence, and breach of Charter rights." It was formally filed in court on October 1. Those long-standing payments of about $1.7 million annually were the result of litigation against the previous provincial administrations, who had committed to continue the funding "until a co-ordinated transition to other services had been made, in a way that provided alternative services with which the families were satisfied", according to The Star. Faced with a backlash against "a botched revamp of autism services" in February 2019, the government had doubled the annual funding to $600 million for autism services but this did not restore the funding for these eight families.
Sources: en.wikipedia.org
=== April === 2 April – The Birmingham Walkathon returns to the city for the first time since 2013. The event, originally organised by Birmingham radio station BRMB, is organised for its 2023 staging by former BRMB director David Bagley and charity Help Harry Help Others. 3 April – NHS England launches its spring booster campaign, which will see around five million people, including those aged over 75 or classed as clinically vulnerable, receive a COVID-19 booster vaccine. The National Education Union announces two further strike dates in England on 27 April and 2 May, stating that the offer from the pay UK government is unacceptable, not fully funded, and does not address a shortage of teachers. Environment Minister Therese Coffey confirms government plans to ban wet wipes containing plastic in England as a means of helping to tackle water pollution. The new England women's national football team kit is unveiled, and it is confirmed they will wear blue shorts at the 2023 World Cup. The change has been made amid period concerns. 4 April – Members of the Association of School and College Leaders overwhelmingly reject the UK government's 4.3% pay offer for teachers in England. 5 April – Twenty one people are convicted over the largest child sex abuse case ever investigated by West Midlands Police. The National Association of Head Teachers becomes the third teaching union to reject the UK government's 4.3% pay offer for teachers in England.
==== Application ==== Some of the applications of these CSPs include the direct chiral analysis of β-adrenergic blockers such as metoprolol and celiprolol, the calcium channel blocker, felodipine and the anticonvulsant agent, ethotoin.
Unlike global alignment approaches, local structural alignment approaches are suited to detection of locally conserved patterns of functional groups, which often appear in binding sites and have significant involvement in ligand binding. As an example, comparing G-Losa, a local structure alignment tool, with TM-align, a global structure alignment based method. While G-Losa predicts drug-like ligands' positions in single-chain protein targets more precisely than TM-align, the overall success rate of TM-align is better. However, as algorithmic improvements and computer performance have erased purely technical deficiencies in older approaches, it has become clear that there is no one universal criterion for the 'optimal' structural alignment. TM-align, for instance, is particularly robust in quantifying comparisons between sets of proteins with great disparities in sequence lengths, but it only indirectly captures hydrogen bonding or secondary structure order conservation which might be better metrics for alignment of evolutionarily related proteins. Thus recent developments have focused on optimizing particular attributes such as speed, quantification of scores, correlation to alternative gold standards, or tolerance of imperfection in structural data or ab initio structural models. An alternative methodology that is gaining popularity is to use the consensus of various methods to ascertain proteins structural similarities.
Sources: en.wikipedia.org
=== Radical anion preparation === In the original ETD experiments anthracene (C14H10) was used to generate reactive radical anions through negative chemical ionization. Several polycyclic aromatic hydrocarbon molecules have been used in subsequent experiments, with fluoranthene currently the preferred reagent. Fluoranthene has only about 40% efficiency in electron transfer, however, so other molecules with low electron affinity are being sought.
=== Moritz-Hunter Bauer === Moritz-Hunter Bauer (Sid Phoenix) is the heir to the Austrian banking family behind IBN Bauer, with which Tender pursues a merger. He raises objections to the deal on data privacy and regulatory grounds, prompting Henry Muck and Whitney Halberstram, Tender's CEO and CFO respectively, to visit his family's castle in Vienna along with Yasmin to negotiate with him. Although Moritz presents his concerns as principled scrutiny, his views increasingly take on fascist overtones: he articulates a critique of liberal democracy and free-market capitalism and instead expresses admiration for authoritarian models of governance, citing Louis XIV as a political inspiration. He also makes an antisemitic insinuation at Whitney during dinner. Henry and Whitney decide not to continue engaging with him, but Yasmin makes a deal with Princess Johanna Bauer, Moritz's mother, to publish Moritz's views in one of Lord Norton's papers in exchange for his backing the merger. The next day, Moritz's article outlining his views, "The Case for a Benevolent Dictatorship", is published in a national column. Moritz and Johanna later attend Yasmin's fundraiser dinner in Paris for far-right MP Sebastian Stefanowicz. The two are seated beside Harper, to whom they make several racist innuendos.
Beta-thalassemia (β-thalassemia) is an inherited blood disorder, a form of thalassemia resulting in variable outcomes ranging from clinically asymptomatic to severely anemic individuals. It is caused by reduced or absent synthesis of the beta chains of hemoglobin, the molecule that carries oxygen in the blood. Symptoms depend on the extent to which hemoglobin is deficient, and include anemia, pallor, tiredness, enlargement of the spleen, jaundice, and gallstones. In severe cases death ensues. Beta thalassemia occurs due to a mutation of the HBB gene leading to deficient production of the hemoglobin subunit beta-globin; the severity of the disease depends on the nature of the mutation, and whether or not the mutation is homozygous. The body's inability to construct beta-globin leads to reduced or zero production of adult hemoglobin thus causing anemia. The other component of hemoglobin, alpha-globin, accumulates in excess leading to ineffective production of red blood cells, increased hemolysis, and iron overload. Diagnosis is by checking the medical history of near relatives, microscopic examination of blood smear, ferritin test, hemoglobin electrophoresis, and DNA sequencing. As an inherited condition, beta thalassemia cannot be prevented although genetic counselling of potential parents prior to conception can propose the use of donor sperm or eggs. Patients may require repeated blood transfusions throughout life to maintain sufficient hemoglobin levels; this in turn may lead to severe problems associated with iron overload.
Sources: en.wikipedia.org
The most common approach is liquid chromatography with tandem mass spectrometry after extraction from blood or urine. Immunoassays exist but are generally treated as screening tools because of cross-reactivity.
Dry lyophilised powder is normally kept frozen and protected from moisture and light. Dissolved material is handled cold and used promptly to limit degradation.
It is not licensed as a medicine in major markets and is distributed as a research chemical. Sports organisations prohibit its use, and some countries restrict import and supply.
No. TB-500 is a short synthetic peptide matching residues 17 to 23 of thymosin beta-4, while the parent protein contains 43 residues. The fragment lacks the rest of the protein sequence, so the two are related but not identical.